JPRN-UMIN000008062已完成未知
A study evaluating efficacy of non-sedative antihistamine up-titration in patients with chronic urticaria who did not respond to standard therapy. - UPDATE trial:Up-dosing antihistamine trial
on-Profit Organization Health Institute Research of Skin0 个研究点目标入组 200 人开始时间: 2012年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with a known allergy to any component of the study drug. 2) Pregnant or possibly pregnant women, or breastfeeding women. Women who wish to become pregnant during study participation. 3) Patients who are judged inappropriate to participate in the study by the investigator.
研究者
相似试验
已完成
4 期
Study on efficacy and safety of aggressive antihypertensive therapy and its effect on QOHypertensionJPRN-UMIN000002918Saga hypertension treatment study group200
已完成
不适用
Study on the safety and efficacy of anticolinergics for children with overactive bladderPediatric overactive bladderJPRN-UMIN000017267Department of Renal and Urologic Surgery, Asahikawa Medical University150
已完成
不适用
Study to establish the safety of using antipyretics with febrile seizures and assess whether acetaminophen could reduce the recurrent risk of febrile seizure in the same fever episode.febrile seizureJPRN-UMIN000028272Department of Pediatrics, Hirakata City Hospital 2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan Tel: +81-72-847-2821; Fax: +81-72-847-2825500
尚未招募
Unknown
Diabetes Management through AyurvedaCTRI/2023/04/051287Aayushi Mogra
进行中（未招募）
1 期
Estudio de la eficacia y seguridad del antihistamínico V0114CP 2.5 mg en el tratamiento de la rinitis alérgica estacional. Estudio aleatorizado, doble ciego, de tres ramas y grupos paralelos, que incluye una rama de placebo y otra de control activo (desloratadina 5 mg). EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (DESLORATADINE 5 MG)Demostrar la eficacia de un tratamiento de 2 semanas con el antihistamínico V0114CP 2,5 mg frente a placebo en la reducción de síntomas de la rinitis alérgica estacionalEUCTR2008-000133-22-ESPierre Fabre Médicament900